SLC5A2 and urogenital neoplasm: In conclusion, we demonstrated that ER stress is involved in the pathogenesis of steatonephropathy, and that an SGLT2 inhibitor, ipragliflozin, attenuates the progression of kidney injury by modifying the lipid profile.